Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life

Vaccine

Volumn 24, Issue 27-28, 2006, Pages 5627-5636

  Knuf, M ^a   Habermehl, P ^a   Faber, J ^a   Bock, H L ^b   Sanger R ^c   Bogaerts, H ^b   Clemens, R ^b   Schuind, A ^b   du Prel, J B ^a   Schmitt, H J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b GSK   (Belgium)

^c GLAXOSMITHKLINE   (Germany)

Author keywords

Booster; DTaP formulations; Immunogenicity; Reactogenicity; Vaccination

Indexed keywords

ADJUVANT; ALUMINUM; ANTIBODY; ANTIGEN; BACTERIAL ANTIGEN; DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; PERTUSSIS VACCINE; TETANUS ANTIBODY;

ANOREXIA; ANTIBODY RESPONSE; ARTICLE; BLOOD; CHILD; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DIPHTHERIA; DOSE RESPONSE; DRUG FEVER; DRUG SAFETY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEBRILE CONVULSION; HUMAN; HYPERACTIVITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFANCY; INJECTION SITE; INJECTION SITE REACTION; LIFE; LIMB; NORMAL HUMAN; PAIN; PARENT; PATHOLOGICAL CRYING; PERTUSSIS; PRIORITY JOURNAL; RESTLESSNESS; SEROLOGY; SERUM; SKIN REDNESS; SLEEP DISORDER; TETANUS; THIGH; VACCINATION; VOMITING;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, BACTERIAL; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE;

EID: 33745108956     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.04.019     Document Type: Article

References (42)

1. http://www.who.int/vaccines/en/pertussis.shtml
2. Schmitt H-J, Wirsing von König CH. Pertussis vaccines 1996, Bailliere's clinical paediatrics, vol. 5, No. 1; February 1997. p. 121.
3. Kimura M., and Kuno-Sakai H.K. Developments in pertussis immunization in Japan. Lancet 336 (1990) 30-32
4. Wiersbitzky S, Bock HL, Bruns R, Clemens R, Graul G, Köditz H, et al. Verträglichkeit und Immunogenität einer 3-Komponenten-azellulären Pertussis Vakzine (DTaP) im Vergleich zur klassischen DTPg-Vakzine Monatsschr Kinderheilkd 1996;144:159-66.
5. Decker M.D., and Edwards K.M. Report of the nationwide multicenter acellular pertussis trial. Pediatrics 96 (1995) S547-S603
6. Calbo F., Dal-Ré R., Díez-Delgado J., Ona S., Sánchez-Prados F., and García-Corbeira P. Comparative trial to assess the reactogenicity of the diphtheria-tetanus-acellular pertussis (DTaP) vaccine plus Haemophilus influenzae type b (Hib) conjugate vaccine and that of the diphtheria-tetanus-whole-cell pertussis (DTPw) vaccine plus Hib conjugate vaccine, administered in single injection as a booster dose to 14-20 months-old children. Med Clin 118 1 (2002) 1-4
7. Schmitt H.-J., Beutel K., Schuind A., Knuf M., Wagner S., Müschenborn S., et al. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at 14-28 month of age. J Pediatr 130 4 (1997) 616-623
8. Rennels M.B., Deloria M.A., Pichichero M.E., Englund J.A., Anderson E.L., Steinhoff M.C., et al. Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 20 Suppl. 3 (2002) S44-S47
9. Scheifele D.W., Halperin S.A., and Fergueson A.C. Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin test with vaccine antigens. Vaccine 19 (2001) 4720-4726
10. Pichichero M.E., Deloria M.A., Rennels M.B., Anderson E.L., Edwards K.M., Decker M.D., et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-20-month-old children. Pediatrics 100 (1997) 772-788
11. Noble G.R., Bernier R.H., Esber E.C., Hardegree C., Hinman A.R., Klein D., et al. Acellular and whole-cell pertussis vaccines in Japan: report of a visit by U.S. scientists. JAMA 257 (1987) 1351-1356 987
12. Kamiya H., Nii R., Matsuda T., Yasuda N., Christenson P.D., and Cherry J.D. Immunogenicity and reactogenicity of Takeda acellular pertussis-component diphtheria-tetanus-pertussis vaccine in 2- and 3-month-old children in Japan. Am J Dis Child 146 (1992) 1141-1147
13. Halperin S.A., Eastwood B.J., Barreto L., Friesen B., Medd L., Meekison W., et al. Adverse reactions and antibody response to four doses of acellular or whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine 14 (1996) 767-772
14. Schmitt H.J., Schuind A., Knuf M., Beutel K., Schulte-Wissermann H., Gahr M., et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J Pediatrics 129 (1996) 695-701
15. Melville-Smith M.E., Seagroatt V.A., and Watkins J.T. A comparison of enzyme linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 11 (1983) 137
16. Melville-Smith M.E., and Balfour A. Estimation of Corynebacterium diphtheria antitoxin in human sera: a comparison of enzyme linked immunosorbent assay (ELISA) with the toxin neutralisation test. J Med Microbiol 25 (1988)
17. Pappenheimer A.M., Edsall G., Lawrence H.S., and Banton H.J. A study of reactions following administration of crude and purified diphtheria toxoid in an adult population. Am J Hyg 52 (1950) 357-370
18. Simonsen O., Badsberg J.H., Kjeldsen K., Moller-Madsen B., and Heron I. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand [C] 94 2 (1986) 77-82
19. Simonsen O., Bentzon M.W., and Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 14 3 (1986) 231-239
20. Blennow M., Granstrom M., and Strandell A. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine 12 5 (1994) 427-430
21. Cody C.L., Baraff L.J., Cherry J.D., Marcy S.M., and Manclark C.R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68 5 (1981) 650-660
22. Relyveld E.H., Bizzini B., and Gupta R.K. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine 16 9-10 (1998) 1016-1023
23. Meekison W., Arcand T., Scheifele D., and Humphreys G. Local adverse reactions to adsorbed DPT vaccine-Surrey* British Columbia. Can Dis Wkly Rep 15 13 (1989) 73-75
24. James G., Longshore W.A., and Hendry J.L. Diphtheria immunization studies of students in an urban high school. Am J Hyg 53 2 (1951) 178-201
25. Rennels M.B., Deloria M.A., Pichichero M.E., Losonsky G.A., Englund J.A., Meade B.D., et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105 1 (2000) e12
26. Galazaka AM, Robertson SE. Immunization against diphtheria with special emphasis on immunization of adults. 1996;14(9):845-57.
27. Pichichero M.E., Rennels M.B., Edwards K.M., Blatter M.M., Marshall G.S., Bologa M., et al. Combined tetanus, diphtheria, and five-component pertussis vaccine for use in adolescents and adults. JAMA 293 24 (2005) 3003-3011
28. Relyveld E.H. Preparation and use of calcium phosphate adsorbed vaccines. Dev Biol Stand 65 (1986) 131-136
29. Theeten H., Van Damme P., Hoppenbrouwers K., Vandermeulen C., Leback E., Sokal E.M., et al. Effects of lowering the aluminum content of a DTaP vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents. Vaccine 23 12 (2005) 1515-1521
30. Hanrahan A., and Waters J. Adverse local reactions to fourth and fifth doses of DPT vaccine, Alberta. Can Dis Wkly Rep 14 11 (1988) 45-47
31. Denoel P., Poolman J., Carletti G., and Veitch K. Effects of adsorption of acellular pertussis antigens onto different aluminum salts on the protective activity in an intranasal murine model of Bordetella pertussis infection. Vaccine 20 (2002) 2551-2555
32. Gupta R.K., and Siber G.R. Comparison of adjuvant activities of aluminum phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid. Biologicals 22 1 (1994) 53-63
33. Collier R.J., Gilliland D.G., and Lory S. Structure-activity relationships in diphtheria toxin and exotoxin A from Pseudomonas aeruginosa. Prog Clin Biol Res 31 (1979) 751-759
34. Aprile M.A., and Wardlaw A.C. Aluminum compounds as adjuvants for vaccines and toxoids in man: a review. Can J Public Health 57 8 (1966) 343-360
35. Frost L., Johansen P., Pedersen S., Veien N., Ostergaard P.A., and Nielsen M.H. Persistent subcutaneous nodules in children hyposensitized with aluminum-containing allergen extracts. Allergy 40 5 (1985) 368-372
36. White J.L., and Schlageter E.A. Diphtheria toxoid. Comparative immunizing value with and without alum, as indicated by Schick test. J Am Med Assoc 102 (1934) 915
37. Erdohazi M., and Newman R.L. Aluminum hydroxide granuloma. Br Med J 3 775 (1971) 621-623
38. Edsall G. Diphtheria, tetanus, and pertussis immunization. Arch Environ Health 15 4 (1967) 473-477
39. Facktor M.A., Bernstein R.A., and Fireman P. Hypersensitivity to tetanus toxoid. J Allergy Clin Immunol 52 1 (1973) 1-12
40. Pappenheimer Jr. A.M. The diphtheria bacillus and its toxin: a model system. J Hyg (Lond) 93 3 (1984) 397-404
41. Picchichero M.E., and Casey J.R. Acellular pertussis vaccines for adolescents. P Infect Dis J 24 6 Suppl. (2005) S117-S126
42. Casey J.R., and Pichichero ME. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs 65 10 (2005) 1367-1389